Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 101,997

Document Document Title
WO/2018/113476A1
The present invention provides a genetically engineered bacterium of coexpressing cyclohexanone monooxygenase and isopropanol dehydrogenase and use thereof, and the genetically engineered bacterium constructed can catalyze and convert hi...  
WO/2018/115042A1
The present invention relates to a method for providing a SCP product from a biomass material wherein said SCP product comprising a reduced amount of nucleic acids relative to the naturally occurring amount of nucleic acids in the biomas...  
WO/2018/115513A1
The present disclosure concerns the use of specific genetic modification(s) for improving sulfite tolerance in recombinant yeast host cells. The genetic modification(s) is (are) designed to allow the expression of an heterologous transcr...  
WO/2018/112639A1
Provided is Metschnikowia strain designated as International Depositary Authority of Canada (ID AC) Accession Number 081116-01, and strains derived therefrom expressing at least one xylose reductase, at least one xylose transporter, and ...  
WO/2018/113245A1
Provided is a genetically engineered Candida utilis capable of degrading and utilizing kitchen waste. The genetically engineered Candida utilis is obtained by means of a Candida utilis multigene co-expression vector integrating alpha-amy...  
WO/2018/113429A1
Provided is a probiotic recombinant Saccharomyces cerevisiae for assisting protein degradation and antimicrobial peptide secretion. The recombinant Saccharomyces cerevisiae contains a Saccharomyces cerevisiae multi-gene co-expression vec...  
WO/2018/114995A1
The invention relates to a process for the production of a steviol glycoside, which process comprises fermenting a first cell capable of producing a steviol glycoside in a suitable fermentation medium under conditions which allow for pro...  
WO/2018/114148A1
The present invention relates to a method for producing fungi of the species Aspergillus oryzae in free mycelium form, comprising at least the following steps: a) a sterilised culture medium A suitable for the growth of the fungus Asperg...  
WO/2018/115333A1
The present invention relates to a fermentation medium comprising: (a) Magnesium at a concentration greater than 40mg/L of the fermentation medium, (b) Sulphur at a concentration greater than 85mg/L of the fermentation medium, (c) Alumin...  
WO/2018/114758A1
This invention relates to a recombinant cell, preferably a recombinant yeast cell comprising: a) a gene coding for an enzyme having glycerol-3-phosphate dehydrogenase activity, wherein said enzyme has a cofactor dependency for at least N...  
WO/2018/114751A1
The present invention relates to a method for induction and production of truffle peridia, comprising the following steps: a. a step of preparing an extract by extraction, with a solvent, from ground truffle plant material, b. optionally...  
WO/2018/113430A1
Provided is a recombinant Saccharomyces cerevisiae for producing a xylo-oligosaccharide and an antimicrobial peptide. The Saccharomyces cerevisiae contains a multi-gene co-expression vector, and the vector contains a specific endo-β-1,4...  
WO/2018/112739A1
Provided are a Bifidobacterium pseudocatenulatum, a culture method therefor and an application thereof. The Bifidobacterium pseudocatenulatum TM12-14 is preserved in Guangdong Microbiological Culture Collection Center, and the preservati...  
WO/2018/112634A1
Metschnikowia strain designated as International Depositary Authority of Canada (IDAC) Accession Number 081116-01 for utilization xylose to produce xylitol and other compounds, and composition and method therefrom.  
WO/2018/115445A1
The present invention provides methods to improve the health and vigor, including enhancement of the growth of plants, including important crop plants. In particular, the present invention provides methods of treating or preventing a rhi...  
WO/2018/116093A1
Provided herein are eukaryotic microorganisms having a simple lipid profile comprising long chain fatty acids (LCFAs). Also provided are compositions and cultures comprising the eukaryotic microorganisms as well as methods of using the e...  
WO/2018/112638A1
Provided is a recombinant Saccharomyces cerevisiae strain comprising a xylose-ethanol pathway and expressing at least one exogenous nucleic acid encoding a xylose transporter, a xylose reductase, a xylose dehydrogenase, and a xylulokinas...  
WO/2018/113431A1
Provided is a multi-functional Saccharomyces cerevisiae capable of degrading a cellulose-producing prebiotic cello-oligosaccharide and secreting an antimicrobial peptide. The recombinant Saccharomyces cerevisiae contains a Saccharomyces ...  
WO/2018/117244A1
Provided is a novel peptide that includes an amino acid sequence indicated by SEQ ID NO: 30, and inhibits protease activity.  
WO/2018/115350A1
The present invention relates to a fermentation medium comprising: (a)Magnesium at a concentration greater than 40mg/L of the fermentation medium, (b)Sulphur at a concentration greater than 85mg/L of the fermentation medium, (c)Aluminium...  
WO/2018/117263A1
Provided herein are compositions and methods for the induction and/or proliferation of CD8+ T-cells. The disclosure also provides methods of treatment of diseases that can be treated by the induction and/or proliferation of CD8+ T-cells.  
WO/2018/117237A1
The present invention provides: a novel antibody capable of binding to human CD3; or a molecule which is capable of binding to an antigen and contains the antibody. Provided are: a novel antibody capable of binding to human CD3; a molecu...  
WO/2018/117263A9
Provided herein are compositions and methods for the induction and/or proliferation of CD8+ T-cells. The disclosure also provides methods of treatment of diseases that can be treated by the induction and/or proliferation of CD8+ T-cells.  
WO/2018/115251A1
The present invention relates to novel nucleic acid sequences encoding bacterial xylose isomerases that upon transformation of a eukaryotic microbial host cell, such as yeast, to confer to the host cell the ability of isomerising xylose ...  
WO/2018/113775A1
Provided are a heparinase producing Pseudomonas stutzeri strain and a heparinase derived therefrom. Further provided are a preparation and application of the heparinase.  
WO/2018/112636A1
Provided are novel xylose transporters and genetically modified transporters derived from a Metschnikowia strain having Accession Number 081116-01, expressed in Metschnikowia strain Accession No. 081116-01 and Saccharomyces cerevisiae, a...  
WO/2018/112740A1
Provided are a Lactobacillus gasseri, a culture method therefor and an application thereof. The Lactobacillus gasseri TF08-1 is preserved in Guangdong Microbiological Culture Collection Center, and the preservation number is GDMCC No: 60...  
WO/2018/117168A1
The purpose of the present invention is to provide: a method for producing polyhydroxyalkanoic acid (PHA) with microbes, the method having an improved PHA productivity; and PHA-producing microbes that are used for said method of producti...  
WO/2018/116301A1
The subject matter discloses a diagnostic apparatus, comprising a disposable cup, a biological detection mechanism secured to an inner sidewall of the disposable cup, an impermeable cover attached to an upper portion of the biological de...  
WO/2018/118740A1
The present disclosure provides stable inoculant compositions and methods for enhancing the survival and/or stability of microorganisms in an inoculant composition. In some embodiments, the microorganisms in an inoculant compositions are...  
WO/2018/112557A1
The invention relates to the isolation or extraction of exosomes.  
WO/2018/111023A1
The present invention relates to lactic acid bacteria having increased stability, and a method for producing same, more specifically to lactic acid bacteria having enhanced storage and thermal stability, acid resistance, bile resistance,...  
WO/2018/110555A1
[Problem] To provide an anti-human CD73 antibody which is potentiated compared with the conventional antibodies and has an ability to recover a suppressed function of a human T cell which is suppressed in an AMP-dependent manner. [Soluti...  
WO/2018/111194A1
The present invention relates to the field of fungal production of a terpene or its derivatives. More specifically, the present invention relates to the production of a terpene or its derivatives in Rhodosporidium genus or Rhodotorula ge...  
WO/2018/112336A1
The present invention relates generally to compositions, systems, and methods for cleaving RNA molecules.  
WO/2018/112371A1
The disclosure provides methods and compositions for determining bacterial integrity.  
WO/2018/111024A1
The present invention relates to lactic acid bacteria having increased stability, and a method for producing same, more specifically to lactic acid bacteria having enhanced storage and thermal stability, acid resistance, bile resistance,...  
WO/2018/110633A1
[Problem] To provide a seasoning having a kelp-like taste and having a high content of mannitol, which is one of the ingredients that contributes to the characteristic flavor of kelp, and to provide a seasoning which has a unique taste a...  
WO/2018/107521A1
Provided are a T4 polynucleotide kinase recombinase and a preparation method, an expression gene, an expression vector, and a host cell of the same. The T4 polynucleotide kinase recombinase comprises: (a) a polypeptide composed of the am...  
WO/2018/110799A1
Provided are a compound represented by any one of chemical formulas 1 to 3, or an isomer, derivative, solvate, or pharmaceutically acceptable salt thereof, a production method therefor, and a use thereof. According to this, antibacterial...  
WO/2018/112378A1
The present invention encompasses compositions and methods to rejuvenate cells by, expanding the replicative life span of the cells for, e.g., use in regenerative therapies. Specifically, the methods and compositions of the present inven...  
WO/2018/112435A1
There are provided compounds for the inhibition of Pin 1 and/or FKBP and methods of use thereof.  
WO/2018/110616A1
The present invention addresses the problem of providing a novel means for reducing the methanol utilization of a host cell and enhancing the yield of a target protein. The present invention solves this problem by providing a host cell...  
WO/2018/109236A1
The present invention relates to compositions containing malt sprouts fraction extracts, their process of preparation and their uses.  
WO/2018/110739A1
The present invention provides, as a bacteria slime-based coating material using bacteria capable of forming slime, a coating material comprising an adsorbent on which slime-forming bacteria are adsorbed, and a binder. According to the p...  
WO/2018/112147A1
Methods for culturing microalgae in ammonia or ammonium toxicity conditions to induce the uptake of nitrogen, increase the metabolic rate, and increase the accumulation of protein, are disclosed. Embodiments include methods of controllin...  
WO/2018/112194A1
Compositions and methods are provided for modulating growth of a genetically modified bacterial cell present in a human organ, for modulating growth of a genetically modified bacterial cell in an organ (e.g., gut), for displacing at leas...  
WO/2018/110641A1
The purpose of the present invention is to provide a method for stably causing high expression of a protein in yeast, and relates specifically to a protein production method including a step for culturing a yeast transformant in which a ...  
WO/2018/107365A1
Provided are Anaerostipes caccae and applications thereof. Specifically provided are applications of Anaerostipes caccae in treating and/or preventing inflammation-related diseases. Also provided are a composition used for treating and/o...  
WO/2018/110595A1
Provided are: a reverse transcriptase mutant including an amino acid mutation at a position corresponding to position 55 of the amino acid sequence of wild-type reverse transcriptase derived from the Moloney murine leukemia virus, wherei...  

Matches 201 - 250 out of 101,997